nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.0516	0.116	CbGbCtD
Risperidone—CYP3A7—Vincristine—sarcoma	0.0516	0.116	CbGbCtD
Risperidone—CYP3A4—Thiotepa—sarcoma	0.051	0.115	CbGbCtD
Risperidone—ABCB1—Dactinomycin—sarcoma	0.0409	0.0919	CbGbCtD
Risperidone—CYP3A5—Vincristine—sarcoma	0.0387	0.087	CbGbCtD
Risperidone—ABCB1—Mitoxantrone—sarcoma	0.0366	0.0823	CbGbCtD
Risperidone—CYP3A5—Etoposide—sarcoma	0.0355	0.0797	CbGbCtD
Risperidone—ABCB1—Vincristine—sarcoma	0.0252	0.0566	CbGbCtD
Risperidone—ABCB1—Etoposide—sarcoma	0.0231	0.0519	CbGbCtD
Risperidone—CYP3A4—Mitoxantrone—sarcoma	0.0219	0.0493	CbGbCtD
Risperidone—HTR1D—meninx—sarcoma	0.0207	0.139	CbGeAlD
Risperidone—HTR1B—dura mater—sarcoma	0.0197	0.132	CbGeAlD
Risperidone—HTR1D—dura mater—sarcoma	0.019	0.128	CbGeAlD
Risperidone—ABCB1—Doxorubicin—sarcoma	0.0157	0.0354	CbGbCtD
Risperidone—CYP3A4—Vincristine—sarcoma	0.0151	0.0339	CbGbCtD
Risperidone—CYP2D6—Doxorubicin—sarcoma	0.0148	0.0333	CbGbCtD
Risperidone—CYP3A4—Etoposide—sarcoma	0.0138	0.0311	CbGbCtD
Risperidone—CYP3A4—Doxorubicin—sarcoma	0.00943	0.0212	CbGbCtD
Risperidone—HTR7—pulmonary artery—sarcoma	0.00647	0.0434	CbGeAlD
Risperidone—HTR2A—pulmonary artery—sarcoma	0.00404	0.0271	CbGeAlD
Risperidone—H1F0—mammary gland—sarcoma	0.00265	0.0177	CbGeAlD
Risperidone—HTR2A—hindlimb—sarcoma	0.00244	0.0164	CbGeAlD
Risperidone—HTR2A—appendage—sarcoma	0.00209	0.014	CbGeAlD
Risperidone—HTR7—endothelium—sarcoma	0.00203	0.0136	CbGeAlD
Risperidone—H1F0—myometrium—sarcoma	0.00188	0.0126	CbGeAlD
Risperidone—H1F0—embryo—sarcoma	0.00181	0.0121	CbGeAlD
Risperidone—DRD4—testis—sarcoma	0.00173	0.0116	CbGeAlD
Risperidone—H1F0—seminal vesicle—sarcoma	0.0017	0.0114	CbGeAlD
Risperidone—H1F0—hematopoietic system—sarcoma	0.00161	0.0108	CbGeAlD
Risperidone—H1F0—connective tissue—sarcoma	0.00155	0.0104	CbGeAlD
Risperidone—H1F0—smooth muscle tissue—sarcoma	0.00142	0.00952	CbGeAlD
Risperidone—H1F0—skin of body—sarcoma	0.0014	0.0094	CbGeAlD
Risperidone—HTR2B—myometrium—sarcoma	0.00135	0.00907	CbGeAlD
Risperidone—HTR2A—endothelium—sarcoma	0.00126	0.00847	CbGeAlD
Risperidone—H1F0—cardiac atrium—sarcoma	0.00123	0.00821	CbGeAlD
Risperidone—H1F0—uterus—sarcoma	0.00122	0.00817	CbGeAlD
Risperidone—HTR1D—connective tissue—sarcoma	0.0012	0.00806	CbGeAlD
Risperidone—H1F0—lymphoid tissue—sarcoma	0.00114	0.00761	CbGeAlD
Risperidone—CYP3A7—liver—sarcoma	0.00113	0.00756	CbGeAlD
Risperidone—KCNH2—myometrium—sarcoma	0.00108	0.00724	CbGeAlD
Risperidone—H1F0—tendon—sarcoma	0.00107	0.00716	CbGeAlD
Risperidone—ADRA2C—myometrium—sarcoma	0.00107	0.00714	CbGeAlD
Risperidone—HTR1A—hematopoietic system—sarcoma	0.00104	0.00698	CbGeAlD
Risperidone—H1F0—bone marrow—sarcoma	0.00103	0.00693	CbGeAlD
Risperidone—HTR2B—smooth muscle tissue—sarcoma	0.00102	0.00686	CbGeAlD
Risperidone—HTR2B—skin of body—sarcoma	0.00101	0.00677	CbGeAlD
Risperidone—HTR7—hematopoietic system—sarcoma	0.000996	0.00667	CbGeAlD
Risperidone—KCNH2—seminal vesicle—sarcoma	0.000976	0.00654	CbGeAlD
Risperidone—ADRA2C—seminal vesicle—sarcoma	0.000963	0.00645	CbGeAlD
Risperidone—ADRA1A—hematopoietic system—sarcoma	0.00096	0.00644	CbGeAlD
Risperidone—CYP3A7-CYP3A51P—liver—sarcoma	0.000959	0.00642	CbGeAlD
Risperidone—HTR7—connective tissue—sarcoma	0.000959	0.00642	CbGeAlD
Risperidone—KCNH2—hematopoietic system—sarcoma	0.000928	0.00622	CbGeAlD
Risperidone—H1F0—testis—sarcoma	0.000884	0.00593	CbGeAlD
Risperidone—HTR2B—uterus—sarcoma	0.000878	0.00589	CbGeAlD
Risperidone—HTR7—smooth muscle tissue—sarcoma	0.000877	0.00588	CbGeAlD
Risperidone—HRH1—myometrium—sarcoma	0.000866	0.0058	CbGeAlD
Risperidone—ADRA2A—myometrium—sarcoma	0.00085	0.0057	CbGeAlD
Risperidone—H1F0—liver—sarcoma	0.000836	0.0056	CbGeAlD
Risperidone—HTR2B—tendon—sarcoma	0.000769	0.00516	CbGeAlD
Risperidone—ADRA2A—seminal vesicle—sarcoma	0.000768	0.00515	CbGeAlD
Risperidone—CYP3A5—hematopoietic system—sarcoma	0.000766	0.00513	CbGeAlD
Risperidone—HRH1—hematopoietic system—sarcoma	0.000743	0.00498	CbGeAlD
Risperidone—ADRA2A—hematopoietic system—sarcoma	0.00073	0.00489	CbGeAlD
Risperidone—HRH1—connective tissue—sarcoma	0.000716	0.0048	CbGeAlD
Risperidone—KCNH2—cardiac atrium—sarcoma	0.000704	0.00472	CbGeAlD
Risperidone—ADRA2A—connective tissue—sarcoma	0.000703	0.00471	CbGeAlD
Risperidone—KCNH2—uterus—sarcoma	0.000701	0.00469	CbGeAlD
Risperidone—HTR2A—embryo—sarcoma	0.000696	0.00466	CbGeAlD
Risperidone—ADRA2C—cardiac atrium—sarcoma	0.000695	0.00466	CbGeAlD
Risperidone—ADRA2C—uterus—sarcoma	0.000691	0.00463	CbGeAlD
Risperidone—ADRA1A—lymphoid tissue—sarcoma	0.000676	0.00453	CbGeAlD
Risperidone—HTR7—tendon—sarcoma	0.000659	0.00442	CbGeAlD
Risperidone—HRH1—smooth muscle tissue—sarcoma	0.000655	0.00439	CbGeAlD
Risperidone—H1F0—lymph node—sarcoma	0.000641	0.00429	CbGeAlD
Risperidone—HTR2A—hematopoietic system—sarcoma	0.000621	0.00416	CbGeAlD
Risperidone—ADRA2C—tendon—sarcoma	0.000606	0.00406	CbGeAlD
Risperidone—HTR2A—connective tissue—sarcoma	0.000598	0.00401	CbGeAlD
Risperidone—KCNH2—bone marrow—sarcoma	0.000595	0.00398	CbGeAlD
Risperidone—CYP3A4—hematopoietic system—sarcoma	0.000575	0.00385	CbGeAlD
Risperidone—CYP2D6—hematopoietic system—sarcoma	0.000566	0.00379	CbGeAlD
Risperidone—ADRA2A—cardiac atrium—sarcoma	0.000554	0.00372	CbGeAlD
Risperidone—ADRA2A—uterus—sarcoma	0.000552	0.0037	CbGeAlD
Risperidone—HTR2A—smooth muscle tissue—sarcoma	0.000547	0.00366	CbGeAlD
Risperidone—HTR7—testis—sarcoma	0.000546	0.00366	CbGeAlD
Risperidone—DRD2—testis—sarcoma	0.000516	0.00346	CbGeAlD
Risperidone—HTR7—liver—sarcoma	0.000516	0.00346	CbGeAlD
Risperidone—KCNH2—testis—sarcoma	0.000508	0.00341	CbGeAlD
Risperidone—ADRA2C—testis—sarcoma	0.000501	0.00336	CbGeAlD
Risperidone—ADRA1A—liver—sarcoma	0.000498	0.00333	CbGeAlD
Risperidone—HRH1—tendon—sarcoma	0.000492	0.0033	CbGeAlD
Risperidone—ADRA2A—tendon—sarcoma	0.000483	0.00324	CbGeAlD
Risperidone—ADRA2C—liver—sarcoma	0.000474	0.00318	CbGeAlD
Risperidone—ABCB1—myometrium—sarcoma	0.000474	0.00318	CbGeAlD
Risperidone—HTR2B—lymph node—sarcoma	0.000462	0.00309	CbGeAlD
Risperidone—ABCB1—embryo—sarcoma	0.000456	0.00305	CbGeAlD
Risperidone—ABCB1—seminal vesicle—sarcoma	0.000428	0.00287	CbGeAlD
Risperidone—HTR2A—tendon—sarcoma	0.000411	0.00275	CbGeAlD
Risperidone—HRH1—testis—sarcoma	0.000407	0.00273	CbGeAlD
Risperidone—ABCB1—hematopoietic system—sarcoma	0.000407	0.00273	CbGeAlD
Risperidone—ADRA2A—testis—sarcoma	0.0004	0.00268	CbGeAlD
Risperidone—CYP3A5—liver—sarcoma	0.000397	0.00266	CbGeAlD
Risperidone—KCNH2—lymph node—sarcoma	0.000368	0.00247	CbGeAlD
Risperidone—ADRA2C—lymph node—sarcoma	0.000364	0.00244	CbGeAlD
Risperidone—HTR2A—testis—sarcoma	0.00034	0.00228	CbGeAlD
Risperidone—HTR2A—liver—sarcoma	0.000322	0.00216	CbGeAlD
Risperidone—CYP2D6—testis—sarcoma	0.00031	0.00208	CbGeAlD
Risperidone—ABCB1—uterus—sarcoma	0.000307	0.00206	CbGeAlD
Risperidone—CYP3A4—liver—sarcoma	0.000298	0.002	CbGeAlD
Risperidone—HRH1—lymph node—sarcoma	0.000295	0.00198	CbGeAlD
Risperidone—CYP2D6—liver—sarcoma	0.000293	0.00196	CbGeAlD
Risperidone—ADRA2A—lymph node—sarcoma	0.00029	0.00194	CbGeAlD
Risperidone—ABCB1—lymphoid tissue—sarcoma	0.000286	0.00192	CbGeAlD
Risperidone—ABCB1—bone marrow—sarcoma	0.000261	0.00175	CbGeAlD
Risperidone—ABCB1—testis—sarcoma	0.000223	0.00149	CbGeAlD
Risperidone—ABCB1—liver—sarcoma	0.000211	0.00141	CbGeAlD
Risperidone—Asthenia—Mitoxantrone—sarcoma	0.000189	0.000469	CcSEcCtD
Risperidone—Fatigue—Etoposide—sarcoma	0.000189	0.000469	CcSEcCtD
Risperidone—Neuropathy peripheral—Epirubicin—sarcoma	0.000189	0.000468	CcSEcCtD
Risperidone—Jaundice—Epirubicin—sarcoma	0.000188	0.000466	CcSEcCtD
Risperidone—Stomatitis—Epirubicin—sarcoma	0.000188	0.000466	CcSEcCtD
Risperidone—Pain—Etoposide—sarcoma	0.000188	0.000465	CcSEcCtD
Risperidone—Constipation—Etoposide—sarcoma	0.000188	0.000465	CcSEcCtD
Risperidone—Urinary tract infection—Epirubicin—sarcoma	0.000187	0.000465	CcSEcCtD
Risperidone—Conjunctivitis—Epirubicin—sarcoma	0.000187	0.000465	CcSEcCtD
Risperidone—Dysuria—Doxorubicin—sarcoma	0.000187	0.000464	CcSEcCtD
Risperidone—Neutropenia—Doxorubicin—sarcoma	0.000187	0.000464	CcSEcCtD
Risperidone—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000186	0.000461	CcSEcCtD
Risperidone—Diarrhoea—Vincristine—sarcoma	0.000185	0.000459	CcSEcCtD
Risperidone—Sweating—Epirubicin—sarcoma	0.000185	0.000458	CcSEcCtD
Risperidone—Pollakiuria—Doxorubicin—sarcoma	0.000185	0.000458	CcSEcCtD
Risperidone—Haematuria—Epirubicin—sarcoma	0.000184	0.000456	CcSEcCtD
Risperidone—Photosensitivity reaction—Doxorubicin—sarcoma	0.000183	0.000453	CcSEcCtD
Risperidone—Hepatobiliary disease—Epirubicin—sarcoma	0.000182	0.000452	CcSEcCtD
Risperidone—Weight increased—Doxorubicin—sarcoma	0.000182	0.000451	CcSEcCtD
Risperidone—Epistaxis—Epirubicin—sarcoma	0.000182	0.000451	CcSEcCtD
Risperidone—Nausea—Thiotepa—sarcoma	0.000181	0.00045	CcSEcCtD
Risperidone—Weight decreased—Doxorubicin—sarcoma	0.000181	0.000449	CcSEcCtD
Risperidone—Sinusitis—Epirubicin—sarcoma	0.000181	0.000448	CcSEcCtD
Risperidone—Feeling abnormal—Etoposide—sarcoma	0.000181	0.000448	CcSEcCtD
Risperidone—Hyperglycaemia—Doxorubicin—sarcoma	0.00018	0.000447	CcSEcCtD
Risperidone—Diarrhoea—Mitoxantrone—sarcoma	0.00018	0.000447	CcSEcCtD
Risperidone—Nausea—Dactinomycin—sarcoma	0.00018	0.000446	CcSEcCtD
Risperidone—Agranulocytosis—Epirubicin—sarcoma	0.00018	0.000446	CcSEcCtD
Risperidone—Pneumonia—Doxorubicin—sarcoma	0.000179	0.000445	CcSEcCtD
Risperidone—Gastrointestinal pain—Etoposide—sarcoma	0.000179	0.000445	CcSEcCtD
Risperidone—Dizziness—Vincristine—sarcoma	0.000179	0.000444	CcSEcCtD
Risperidone—Drowsiness—Doxorubicin—sarcoma	0.000178	0.000442	CcSEcCtD
Risperidone—Infestation NOS—Doxorubicin—sarcoma	0.000178	0.000442	CcSEcCtD
Risperidone—Infestation—Doxorubicin—sarcoma	0.000178	0.000442	CcSEcCtD
Risperidone—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000177	0.000438	CcSEcCtD
Risperidone—Bradycardia—Epirubicin—sarcoma	0.000176	0.000437	CcSEcCtD
Risperidone—Renal failure—Doxorubicin—sarcoma	0.000175	0.000435	CcSEcCtD
Risperidone—Neuropathy peripheral—Doxorubicin—sarcoma	0.000175	0.000433	CcSEcCtD
Risperidone—Urticaria—Etoposide—sarcoma	0.000174	0.000432	CcSEcCtD
Risperidone—Haemoglobin—Epirubicin—sarcoma	0.000174	0.000431	CcSEcCtD
Risperidone—Stomatitis—Doxorubicin—sarcoma	0.000174	0.000431	CcSEcCtD
Risperidone—Jaundice—Doxorubicin—sarcoma	0.000174	0.000431	CcSEcCtD
Risperidone—Rhinitis—Epirubicin—sarcoma	0.000173	0.00043	CcSEcCtD
Risperidone—Body temperature increased—Etoposide—sarcoma	0.000173	0.00043	CcSEcCtD
Risperidone—Abdominal pain—Etoposide—sarcoma	0.000173	0.00043	CcSEcCtD
Risperidone—Urinary tract infection—Doxorubicin—sarcoma	0.000173	0.00043	CcSEcCtD
Risperidone—Conjunctivitis—Doxorubicin—sarcoma	0.000173	0.00043	CcSEcCtD
Risperidone—Haemorrhage—Epirubicin—sarcoma	0.000173	0.000429	CcSEcCtD
Risperidone—Hepatitis—Epirubicin—sarcoma	0.000173	0.000429	CcSEcCtD
Risperidone—Hypoaesthesia—Epirubicin—sarcoma	0.000172	0.000427	CcSEcCtD
Risperidone—Vomiting—Vincristine—sarcoma	0.000172	0.000427	CcSEcCtD
Risperidone—Pharyngitis—Epirubicin—sarcoma	0.000172	0.000426	CcSEcCtD
Risperidone—Sweating—Doxorubicin—sarcoma	0.000171	0.000424	CcSEcCtD
Risperidone—Urinary tract disorder—Epirubicin—sarcoma	0.000171	0.000424	CcSEcCtD
Risperidone—Rash—Vincristine—sarcoma	0.000171	0.000423	CcSEcCtD
Risperidone—Dermatitis—Vincristine—sarcoma	0.000171	0.000423	CcSEcCtD
Risperidone—Oedema peripheral—Epirubicin—sarcoma	0.00017	0.000423	CcSEcCtD
Risperidone—Haematuria—Doxorubicin—sarcoma	0.00017	0.000422	CcSEcCtD
Risperidone—Connective tissue disorder—Epirubicin—sarcoma	0.00017	0.000422	CcSEcCtD
Risperidone—Urethral disorder—Epirubicin—sarcoma	0.00017	0.000421	CcSEcCtD
Risperidone—Headache—Vincristine—sarcoma	0.00017	0.00042	CcSEcCtD
Risperidone—Hepatobiliary disease—Doxorubicin—sarcoma	0.000169	0.000418	CcSEcCtD
Risperidone—Epistaxis—Doxorubicin—sarcoma	0.000168	0.000417	CcSEcCtD
Risperidone—Vomiting—Mitoxantrone—sarcoma	0.000168	0.000416	CcSEcCtD
Risperidone—Sinusitis—Doxorubicin—sarcoma	0.000167	0.000415	CcSEcCtD
Risperidone—Visual impairment—Epirubicin—sarcoma	0.000167	0.000413	CcSEcCtD
Risperidone—Agranulocytosis—Doxorubicin—sarcoma	0.000166	0.000413	CcSEcCtD
Risperidone—Rash—Mitoxantrone—sarcoma	0.000166	0.000412	CcSEcCtD
Risperidone—Dermatitis—Mitoxantrone—sarcoma	0.000166	0.000412	CcSEcCtD
Risperidone—Headache—Mitoxantrone—sarcoma	0.000165	0.00041	CcSEcCtD
Risperidone—Erythema multiforme—Epirubicin—sarcoma	0.000164	0.000406	CcSEcCtD
Risperidone—Bradycardia—Doxorubicin—sarcoma	0.000163	0.000404	CcSEcCtD
Risperidone—Eye disorder—Epirubicin—sarcoma	0.000162	0.000401	CcSEcCtD
Risperidone—ABCB1—lymph node—sarcoma	0.000162	0.00108	CbGeAlD
Risperidone—Hypersensitivity—Etoposide—sarcoma	0.000162	0.000401	CcSEcCtD
Risperidone—Tinnitus—Epirubicin—sarcoma	0.000161	0.0004	CcSEcCtD
Risperidone—Haemoglobin—Doxorubicin—sarcoma	0.000161	0.000399	CcSEcCtD
Risperidone—Nausea—Vincristine—sarcoma	0.000161	0.000399	CcSEcCtD
Risperidone—Flushing—Epirubicin—sarcoma	0.000161	0.000398	CcSEcCtD
Risperidone—Cardiac disorder—Epirubicin—sarcoma	0.000161	0.000398	CcSEcCtD
Risperidone—Rhinitis—Doxorubicin—sarcoma	0.000161	0.000398	CcSEcCtD
Risperidone—Haemorrhage—Doxorubicin—sarcoma	0.00016	0.000397	CcSEcCtD
Risperidone—Hepatitis—Doxorubicin—sarcoma	0.00016	0.000397	CcSEcCtD
Risperidone—Hypoaesthesia—Doxorubicin—sarcoma	0.000159	0.000395	CcSEcCtD
Risperidone—Pharyngitis—Doxorubicin—sarcoma	0.000159	0.000394	CcSEcCtD
Risperidone—Urinary tract disorder—Doxorubicin—sarcoma	0.000158	0.000392	CcSEcCtD
Risperidone—Oedema peripheral—Doxorubicin—sarcoma	0.000158	0.000391	CcSEcCtD
Risperidone—Asthenia—Etoposide—sarcoma	0.000157	0.00039	CcSEcCtD
Risperidone—Connective tissue disorder—Doxorubicin—sarcoma	0.000157	0.00039	CcSEcCtD
Risperidone—Angiopathy—Epirubicin—sarcoma	0.000157	0.000389	CcSEcCtD
Risperidone—Urethral disorder—Doxorubicin—sarcoma	0.000157	0.000389	CcSEcCtD
Risperidone—Nausea—Mitoxantrone—sarcoma	0.000157	0.000388	CcSEcCtD
Risperidone—Immune system disorder—Epirubicin—sarcoma	0.000156	0.000387	CcSEcCtD
Risperidone—Mediastinal disorder—Epirubicin—sarcoma	0.000156	0.000387	CcSEcCtD
Risperidone—Chills—Epirubicin—sarcoma	0.000155	0.000385	CcSEcCtD
Risperidone—Pruritus—Etoposide—sarcoma	0.000155	0.000385	CcSEcCtD
Risperidone—Arrhythmia—Epirubicin—sarcoma	0.000155	0.000383	CcSEcCtD
Risperidone—Visual impairment—Doxorubicin—sarcoma	0.000154	0.000383	CcSEcCtD
Risperidone—Alopecia—Epirubicin—sarcoma	0.000153	0.000379	CcSEcCtD
Risperidone—Mental disorder—Epirubicin—sarcoma	0.000152	0.000376	CcSEcCtD
Risperidone—Erythema multiforme—Doxorubicin—sarcoma	0.000151	0.000375	CcSEcCtD
Risperidone—Malnutrition—Epirubicin—sarcoma	0.000151	0.000373	CcSEcCtD
Risperidone—Erythema—Epirubicin—sarcoma	0.000151	0.000373	CcSEcCtD
Risperidone—Diarrhoea—Etoposide—sarcoma	0.00015	0.000372	CcSEcCtD
Risperidone—Eye disorder—Doxorubicin—sarcoma	0.00015	0.000371	CcSEcCtD
Risperidone—Tinnitus—Doxorubicin—sarcoma	0.000149	0.00037	CcSEcCtD
Risperidone—Flushing—Doxorubicin—sarcoma	0.000149	0.000368	CcSEcCtD
Risperidone—Cardiac disorder—Doxorubicin—sarcoma	0.000149	0.000368	CcSEcCtD
Risperidone—Flatulence—Epirubicin—sarcoma	0.000148	0.000368	CcSEcCtD
Risperidone—Tension—Epirubicin—sarcoma	0.000148	0.000366	CcSEcCtD
Risperidone—Dysgeusia—Epirubicin—sarcoma	0.000148	0.000366	CcSEcCtD
Risperidone—Nervousness—Epirubicin—sarcoma	0.000146	0.000363	CcSEcCtD
Risperidone—Back pain—Epirubicin—sarcoma	0.000146	0.000361	CcSEcCtD
Risperidone—Angiopathy—Doxorubicin—sarcoma	0.000145	0.00036	CcSEcCtD
Risperidone—Dizziness—Etoposide—sarcoma	0.000145	0.00036	CcSEcCtD
Risperidone—Muscle spasms—Epirubicin—sarcoma	0.000145	0.000359	CcSEcCtD
Risperidone—Immune system disorder—Doxorubicin—sarcoma	0.000145	0.000359	CcSEcCtD
Risperidone—Mediastinal disorder—Doxorubicin—sarcoma	0.000144	0.000358	CcSEcCtD
Risperidone—Chills—Doxorubicin—sarcoma	0.000144	0.000356	CcSEcCtD
Risperidone—Arrhythmia—Doxorubicin—sarcoma	0.000143	0.000355	CcSEcCtD
Risperidone—Vision blurred—Epirubicin—sarcoma	0.000142	0.000352	CcSEcCtD
Risperidone—Alopecia—Doxorubicin—sarcoma	0.000141	0.000351	CcSEcCtD
Risperidone—Mental disorder—Doxorubicin—sarcoma	0.00014	0.000348	CcSEcCtD
Risperidone—Ill-defined disorder—Epirubicin—sarcoma	0.00014	0.000346	CcSEcCtD
Risperidone—Vomiting—Etoposide—sarcoma	0.000139	0.000346	CcSEcCtD
Risperidone—Malnutrition—Doxorubicin—sarcoma	0.000139	0.000346	CcSEcCtD
Risperidone—Erythema—Doxorubicin—sarcoma	0.000139	0.000346	CcSEcCtD
Risperidone—Anaemia—Epirubicin—sarcoma	0.000139	0.000345	CcSEcCtD
Risperidone—Agitation—Epirubicin—sarcoma	0.000138	0.000343	CcSEcCtD
Risperidone—Rash—Etoposide—sarcoma	0.000138	0.000343	CcSEcCtD
Risperidone—Dermatitis—Etoposide—sarcoma	0.000138	0.000343	CcSEcCtD
Risperidone—Headache—Etoposide—sarcoma	0.000137	0.000341	CcSEcCtD
Risperidone—Flatulence—Doxorubicin—sarcoma	0.000137	0.00034	CcSEcCtD
Risperidone—Tension—Doxorubicin—sarcoma	0.000137	0.000339	CcSEcCtD
Risperidone—Dysgeusia—Doxorubicin—sarcoma	0.000137	0.000338	CcSEcCtD
Risperidone—Malaise—Epirubicin—sarcoma	0.000136	0.000337	CcSEcCtD
Risperidone—Nervousness—Doxorubicin—sarcoma	0.000135	0.000336	CcSEcCtD
Risperidone—Vertigo—Epirubicin—sarcoma	0.000135	0.000336	CcSEcCtD
Risperidone—Syncope—Epirubicin—sarcoma	0.000135	0.000335	CcSEcCtD
Risperidone—Leukopenia—Epirubicin—sarcoma	0.000135	0.000334	CcSEcCtD
Risperidone—Back pain—Doxorubicin—sarcoma	0.000135	0.000334	CcSEcCtD
Risperidone—Muscle spasms—Doxorubicin—sarcoma	0.000134	0.000332	CcSEcCtD
Risperidone—Palpitations—Epirubicin—sarcoma	0.000133	0.00033	CcSEcCtD
Risperidone—Loss of consciousness—Epirubicin—sarcoma	0.000132	0.000328	CcSEcCtD
Risperidone—Cough—Epirubicin—sarcoma	0.000131	0.000326	CcSEcCtD
Risperidone—Vision blurred—Doxorubicin—sarcoma	0.000131	0.000326	CcSEcCtD
Risperidone—Convulsion—Epirubicin—sarcoma	0.000131	0.000324	CcSEcCtD
Risperidone—Nausea—Etoposide—sarcoma	0.00013	0.000323	CcSEcCtD
Risperidone—Hypertension—Epirubicin—sarcoma	0.00013	0.000322	CcSEcCtD
Risperidone—Ill-defined disorder—Doxorubicin—sarcoma	0.000129	0.000321	CcSEcCtD
Risperidone—Anaemia—Doxorubicin—sarcoma	0.000129	0.000319	CcSEcCtD
Risperidone—Arthralgia—Epirubicin—sarcoma	0.000128	0.000318	CcSEcCtD
Risperidone—Myalgia—Epirubicin—sarcoma	0.000128	0.000318	CcSEcCtD
Risperidone—Chest pain—Epirubicin—sarcoma	0.000128	0.000318	CcSEcCtD
Risperidone—Agitation—Doxorubicin—sarcoma	0.000128	0.000318	CcSEcCtD
Risperidone—Anxiety—Epirubicin—sarcoma	0.000128	0.000317	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000127	0.000316	CcSEcCtD
Risperidone—Discomfort—Epirubicin—sarcoma	0.000127	0.000314	CcSEcCtD
Risperidone—Malaise—Doxorubicin—sarcoma	0.000126	0.000312	CcSEcCtD
Risperidone—Dry mouth—Epirubicin—sarcoma	0.000125	0.000311	CcSEcCtD
Risperidone—Vertigo—Doxorubicin—sarcoma	0.000125	0.00031	CcSEcCtD
Risperidone—Syncope—Doxorubicin—sarcoma	0.000125	0.00031	CcSEcCtD
Risperidone—Leukopenia—Doxorubicin—sarcoma	0.000125	0.000309	CcSEcCtD
Risperidone—Confusional state—Epirubicin—sarcoma	0.000124	0.000307	CcSEcCtD
Risperidone—Palpitations—Doxorubicin—sarcoma	0.000123	0.000305	CcSEcCtD
Risperidone—Oedema—Epirubicin—sarcoma	0.000123	0.000305	CcSEcCtD
Risperidone—Anaphylactic shock—Epirubicin—sarcoma	0.000123	0.000305	CcSEcCtD
Risperidone—Loss of consciousness—Doxorubicin—sarcoma	0.000123	0.000304	CcSEcCtD
Risperidone—Infection—Epirubicin—sarcoma	0.000122	0.000303	CcSEcCtD
Risperidone—Cough—Doxorubicin—sarcoma	0.000122	0.000302	CcSEcCtD
Risperidone—Shock—Epirubicin—sarcoma	0.000121	0.0003	CcSEcCtD
Risperidone—Convulsion—Doxorubicin—sarcoma	0.000121	0.000299	CcSEcCtD
Risperidone—Nervous system disorder—Epirubicin—sarcoma	0.000121	0.000299	CcSEcCtD
Risperidone—Thrombocytopenia—Epirubicin—sarcoma	0.00012	0.000298	CcSEcCtD
Risperidone—Hypertension—Doxorubicin—sarcoma	0.00012	0.000298	CcSEcCtD
Risperidone—Tachycardia—Epirubicin—sarcoma	0.00012	0.000297	CcSEcCtD
Risperidone—Skin disorder—Epirubicin—sarcoma	0.000119	0.000296	CcSEcCtD
Risperidone—Hyperhidrosis—Epirubicin—sarcoma	0.000119	0.000295	CcSEcCtD
Risperidone—Chest pain—Doxorubicin—sarcoma	0.000119	0.000294	CcSEcCtD
Risperidone—Myalgia—Doxorubicin—sarcoma	0.000119	0.000294	CcSEcCtD
Risperidone—Arthralgia—Doxorubicin—sarcoma	0.000119	0.000294	CcSEcCtD
Risperidone—Anxiety—Doxorubicin—sarcoma	0.000118	0.000293	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000118	0.000292	CcSEcCtD
Risperidone—Discomfort—Doxorubicin—sarcoma	0.000117	0.000291	CcSEcCtD
Risperidone—Anorexia—Epirubicin—sarcoma	0.000117	0.000291	CcSEcCtD
Risperidone—Dry mouth—Doxorubicin—sarcoma	0.000116	0.000288	CcSEcCtD
Risperidone—Hypotension—Epirubicin—sarcoma	0.000115	0.000285	CcSEcCtD
Risperidone—Confusional state—Doxorubicin—sarcoma	0.000115	0.000284	CcSEcCtD
Risperidone—Anaphylactic shock—Doxorubicin—sarcoma	0.000114	0.000282	CcSEcCtD
Risperidone—Oedema—Doxorubicin—sarcoma	0.000114	0.000282	CcSEcCtD
Risperidone—Infection—Doxorubicin—sarcoma	0.000113	0.00028	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000112	0.000278	CcSEcCtD
Risperidone—Shock—Doxorubicin—sarcoma	0.000112	0.000277	CcSEcCtD
Risperidone—Nervous system disorder—Doxorubicin—sarcoma	0.000112	0.000277	CcSEcCtD
Risperidone—Thrombocytopenia—Doxorubicin—sarcoma	0.000111	0.000276	CcSEcCtD
Risperidone—Insomnia—Epirubicin—sarcoma	0.000111	0.000276	CcSEcCtD
Risperidone—Tachycardia—Doxorubicin—sarcoma	0.000111	0.000275	CcSEcCtD
Risperidone—Skin disorder—Doxorubicin—sarcoma	0.000111	0.000274	CcSEcCtD
Risperidone—Paraesthesia—Epirubicin—sarcoma	0.00011	0.000274	CcSEcCtD
Risperidone—Hyperhidrosis—Doxorubicin—sarcoma	0.00011	0.000273	CcSEcCtD
Risperidone—Dyspnoea—Epirubicin—sarcoma	0.00011	0.000272	CcSEcCtD
Risperidone—Somnolence—Epirubicin—sarcoma	0.000109	0.000271	CcSEcCtD
Risperidone—Anorexia—Doxorubicin—sarcoma	0.000108	0.000269	CcSEcCtD
Risperidone—Dyspepsia—Epirubicin—sarcoma	0.000108	0.000268	CcSEcCtD
Risperidone—Decreased appetite—Epirubicin—sarcoma	0.000107	0.000265	CcSEcCtD
Risperidone—Hypotension—Doxorubicin—sarcoma	0.000106	0.000264	CcSEcCtD
Risperidone—Gastrointestinal disorder—Epirubicin—sarcoma	0.000106	0.000263	CcSEcCtD
Risperidone—Fatigue—Epirubicin—sarcoma	0.000106	0.000263	CcSEcCtD
Risperidone—Pain—Epirubicin—sarcoma	0.000105	0.000261	CcSEcCtD
Risperidone—Constipation—Epirubicin—sarcoma	0.000105	0.000261	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000104	0.000257	CcSEcCtD
Risperidone—Insomnia—Doxorubicin—sarcoma	0.000103	0.000255	CcSEcCtD
Risperidone—Paraesthesia—Doxorubicin—sarcoma	0.000102	0.000253	CcSEcCtD
Risperidone—Dyspnoea—Doxorubicin—sarcoma	0.000101	0.000251	CcSEcCtD
Risperidone—Feeling abnormal—Epirubicin—sarcoma	0.000101	0.000251	CcSEcCtD
Risperidone—Somnolence—Doxorubicin—sarcoma	0.000101	0.000251	CcSEcCtD
Risperidone—Gastrointestinal pain—Epirubicin—sarcoma	0.000101	0.000249	CcSEcCtD
Risperidone—Dyspepsia—Doxorubicin—sarcoma	0.0001	0.000248	CcSEcCtD
Risperidone—Decreased appetite—Doxorubicin—sarcoma	9.89e-05	0.000245	CcSEcCtD
Risperidone—Gastrointestinal disorder—Doxorubicin—sarcoma	9.82e-05	0.000243	CcSEcCtD
Risperidone—Fatigue—Doxorubicin—sarcoma	9.81e-05	0.000243	CcSEcCtD
Risperidone—Urticaria—Epirubicin—sarcoma	9.77e-05	0.000242	CcSEcCtD
Risperidone—Pain—Doxorubicin—sarcoma	9.73e-05	0.000241	CcSEcCtD
Risperidone—Constipation—Doxorubicin—sarcoma	9.73e-05	0.000241	CcSEcCtD
Risperidone—Abdominal pain—Epirubicin—sarcoma	9.72e-05	0.000241	CcSEcCtD
Risperidone—Body temperature increased—Epirubicin—sarcoma	9.72e-05	0.000241	CcSEcCtD
Risperidone—Feeling abnormal—Doxorubicin—sarcoma	9.37e-05	0.000232	CcSEcCtD
Risperidone—Gastrointestinal pain—Doxorubicin—sarcoma	9.3e-05	0.000231	CcSEcCtD
Risperidone—Hypersensitivity—Epirubicin—sarcoma	9.06e-05	0.000225	CcSEcCtD
Risperidone—Urticaria—Doxorubicin—sarcoma	9.04e-05	0.000224	CcSEcCtD
Risperidone—Abdominal pain—Doxorubicin—sarcoma	8.99e-05	0.000223	CcSEcCtD
Risperidone—Body temperature increased—Doxorubicin—sarcoma	8.99e-05	0.000223	CcSEcCtD
Risperidone—Asthenia—Epirubicin—sarcoma	8.82e-05	0.000219	CcSEcCtD
Risperidone—Pruritus—Epirubicin—sarcoma	8.7e-05	0.000216	CcSEcCtD
Risperidone—Diarrhoea—Epirubicin—sarcoma	8.41e-05	0.000209	CcSEcCtD
Risperidone—Hypersensitivity—Doxorubicin—sarcoma	8.38e-05	0.000208	CcSEcCtD
Risperidone—Asthenia—Doxorubicin—sarcoma	8.16e-05	0.000202	CcSEcCtD
Risperidone—Dizziness—Epirubicin—sarcoma	8.13e-05	0.000202	CcSEcCtD
Risperidone—Pruritus—Doxorubicin—sarcoma	8.05e-05	0.0002	CcSEcCtD
Risperidone—Vomiting—Epirubicin—sarcoma	7.82e-05	0.000194	CcSEcCtD
Risperidone—Diarrhoea—Doxorubicin—sarcoma	7.78e-05	0.000193	CcSEcCtD
Risperidone—Rash—Epirubicin—sarcoma	7.75e-05	0.000192	CcSEcCtD
Risperidone—Dermatitis—Epirubicin—sarcoma	7.75e-05	0.000192	CcSEcCtD
Risperidone—Headache—Epirubicin—sarcoma	7.7e-05	0.000191	CcSEcCtD
Risperidone—Dizziness—Doxorubicin—sarcoma	7.52e-05	0.000186	CcSEcCtD
Risperidone—Nausea—Epirubicin—sarcoma	7.3e-05	0.000181	CcSEcCtD
Risperidone—Vomiting—Doxorubicin—sarcoma	7.23e-05	0.000179	CcSEcCtD
Risperidone—Rash—Doxorubicin—sarcoma	7.17e-05	0.000178	CcSEcCtD
Risperidone—Dermatitis—Doxorubicin—sarcoma	7.17e-05	0.000178	CcSEcCtD
Risperidone—Headache—Doxorubicin—sarcoma	7.13e-05	0.000177	CcSEcCtD
Risperidone—Nausea—Doxorubicin—sarcoma	6.76e-05	0.000168	CcSEcCtD
Risperidone—HTR1B—Signaling Pathways—CTNNB1—sarcoma	6.68e-07	0.000275	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—KRAS—sarcoma	6.68e-07	0.000275	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—CCND1—sarcoma	6.64e-07	0.000274	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—JUN—sarcoma	6.62e-07	0.000273	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—EGFR—sarcoma	6.6e-07	0.000272	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—KIT—sarcoma	6.58e-07	0.000271	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—NRAS—sarcoma	6.58e-07	0.000271	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—CTNNB1—sarcoma	6.57e-07	0.000271	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ENO2—sarcoma	6.54e-07	0.00027	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—IL2—sarcoma	6.5e-07	0.000268	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—EGFR—sarcoma	6.5e-07	0.000268	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—HBA1—sarcoma	6.5e-07	0.000268	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—KIT—sarcoma	6.47e-07	0.000267	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—NRAS—sarcoma	6.47e-07	0.000267	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—KIT—sarcoma	6.46e-07	0.000266	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—NRAS—sarcoma	6.46e-07	0.000266	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—KRAS—sarcoma	6.45e-07	0.000266	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—KRAS—sarcoma	6.41e-07	0.000265	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—KDR—sarcoma	6.39e-07	0.000264	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—HRAS—sarcoma	6.37e-07	0.000263	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—CCND1—sarcoma	6.34e-07	0.000261	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—KIT—sarcoma	6.34e-07	0.000261	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—NRAS—sarcoma	6.33e-07	0.000261	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—JUN—sarcoma	6.32e-07	0.000261	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—HRAS—sarcoma	6.29e-07	0.000259	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—CTNNB1—sarcoma	6.27e-07	0.000259	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CREB1—sarcoma	6.26e-07	0.000258	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—KRAS—sarcoma	6.24e-07	0.000257	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—SRC—sarcoma	6.21e-07	0.000256	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—SRC—sarcoma	6.17e-07	0.000254	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CREB1—sarcoma	6.16e-07	0.000254	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CREB1—sarcoma	6.15e-07	0.000253	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—KRAS—sarcoma	6.14e-07	0.000253	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—IL2—sarcoma	6.13e-07	0.000253	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MDM2—sarcoma	6.11e-07	0.000252	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—IL2—sarcoma	6.05e-07	0.000249	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—VEGFA—sarcoma	6.04e-07	0.000249	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—SRC—sarcoma	6.04e-07	0.000249	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CREB1—sarcoma	6.03e-07	0.000249	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—VEGFA—sarcoma	6e-07	0.000248	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—EGFR—sarcoma	5.99e-07	0.000247	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—CCND1—sarcoma	5.97e-07	0.000246	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—NRAS—sarcoma	5.97e-07	0.000246	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—JUN—sarcoma	5.96e-07	0.000246	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—SRC—sarcoma	5.94e-07	0.000245	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—NRAS—sarcoma	5.93e-07	0.000245	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—CTNNB1—sarcoma	5.92e-07	0.000244	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MDM2—sarcoma	5.9e-07	0.000243	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—CCND1—sarcoma	5.89e-07	0.000243	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—EGFR—sarcoma	5.89e-07	0.000243	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—KIT—sarcoma	5.89e-07	0.000243	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—NRAS—sarcoma	5.89e-07	0.000243	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—JUN—sarcoma	5.88e-07	0.000243	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—EGFR—sarcoma	5.88e-07	0.000243	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—VEGFA—sarcoma	5.88e-07	0.000243	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MDM2—sarcoma	5.87e-07	0.000242	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—CTNNB1—sarcoma	5.84e-07	0.000241	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—NRAS—sarcoma	5.81e-07	0.00024	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—VEGFA—sarcoma	5.79e-07	0.000239	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—EGFR—sarcoma	5.77e-07	0.000238	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—NRAS—sarcoma	5.71e-07	0.000236	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MDM2—sarcoma	5.71e-07	0.000235	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—HRAS—sarcoma	5.68e-07	0.000234	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—SRC—sarcoma	5.67e-07	0.000234	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—KRAS—sarcoma	5.66e-07	0.000233	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MDM2—sarcoma	5.62e-07	0.000232	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CREB1—sarcoma	5.6e-07	0.000231	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—KRAS—sarcoma	5.57e-07	0.00023	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—MYC—sarcoma	5.56e-07	0.000229	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—KRAS—sarcoma	5.56e-07	0.000229	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PLCG1—sarcoma	5.55e-07	0.000229	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—MYC—sarcoma	5.52e-07	0.000228	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—VEGFA—sarcoma	5.52e-07	0.000228	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—HRAS—sarcoma	5.48e-07	0.000226	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—IL2—sarcoma	5.46e-07	0.000225	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—NRAS—sarcoma	5.46e-07	0.000225	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—KRAS—sarcoma	5.45e-07	0.000225	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—HRAS—sarcoma	5.45e-07	0.000225	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—EGFR—sarcoma	5.44e-07	0.000224	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—MYC—sarcoma	5.41e-07	0.000223	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—EGFR—sarcoma	5.4e-07	0.000223	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—EGFR—sarcoma	5.36e-07	0.000221	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—SRC—sarcoma	5.35e-07	0.000221	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—MYC—sarcoma	5.32e-07	0.00022	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CCND1—sarcoma	5.32e-07	0.00022	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—JUN—sarcoma	5.31e-07	0.000219	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—HRAS—sarcoma	5.3e-07	0.000219	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—EGFR—sarcoma	5.29e-07	0.000218	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—SRC—sarcoma	5.28e-07	0.000218	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CTNNB1—sarcoma	5.27e-07	0.000217	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IL2—sarcoma	5.27e-07	0.000217	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IL2—sarcoma	5.24e-07	0.000216	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—HRAS—sarcoma	5.22e-07	0.000215	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—VEGFA—sarcoma	5.21e-07	0.000215	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—EGFR—sarcoma	5.21e-07	0.000215	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MDM2—sarcoma	5.18e-07	0.000214	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—NRAS—sarcoma	5.14e-07	0.000212	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—VEGFA—sarcoma	5.14e-07	0.000212	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—KRAS—sarcoma	5.14e-07	0.000212	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CCND1—sarcoma	5.14e-07	0.000212	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—JUN—sarcoma	5.13e-07	0.000211	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CCND1—sarcoma	5.11e-07	0.000211	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—KRAS—sarcoma	5.1e-07	0.000211	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—JUN—sarcoma	5.1e-07	0.00021	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IL2—sarcoma	5.1e-07	0.00021	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MDM2—sarcoma	5.1e-07	0.00021	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CTNNB1—sarcoma	5.09e-07	0.00021	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MDM2—sarcoma	5.08e-07	0.00021	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—MYC—sarcoma	5.08e-07	0.00021	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—NRAS—sarcoma	5.08e-07	0.000209	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—KRAS—sarcoma	5.07e-07	0.000209	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CTNNB1—sarcoma	5.06e-07	0.000209	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IL2—sarcoma	5.02e-07	0.000207	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—KRAS—sarcoma	5e-07	0.000206	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MDM2—sarcoma	4.99e-07	0.000206	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CCND1—sarcoma	4.97e-07	0.000205	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—EGFR—sarcoma	4.97e-07	0.000205	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—JUN—sarcoma	4.96e-07	0.000205	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CTNNB1—sarcoma	4.92e-07	0.000203	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—KRAS—sarcoma	4.92e-07	0.000203	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CCND1—sarcoma	4.89e-07	0.000202	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—JUN—sarcoma	4.88e-07	0.000201	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CTNNB1—sarcoma	4.85e-07	0.0002	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—HRAS—sarcoma	4.81e-07	0.000198	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—MYC—sarcoma	4.79e-07	0.000198	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—SRC—sarcoma	4.76e-07	0.000196	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—HRAS—sarcoma	4.73e-07	0.000195	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—MYC—sarcoma	4.73e-07	0.000195	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—HRAS—sarcoma	4.72e-07	0.000195	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—KRAS—sarcoma	4.7e-07	0.000194	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—EGFR—sarcoma	4.69e-07	0.000193	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—VEGFA—sarcoma	4.64e-07	0.000191	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MDM2—sarcoma	4.64e-07	0.000191	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—HRAS—sarcoma	4.63e-07	0.000191	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IL2—sarcoma	4.63e-07	0.000191	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—EGFR—sarcoma	4.62e-07	0.000191	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—SRC—sarcoma	4.6e-07	0.00019	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—NRAS—sarcoma	4.58e-07	0.000189	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—SRC—sarcoma	4.57e-07	0.000189	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TP53—sarcoma	4.57e-07	0.000188	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IL2—sarcoma	4.55e-07	0.000188	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IL2—sarcoma	4.54e-07	0.000187	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TP53—sarcoma	4.54e-07	0.000187	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CCND1—sarcoma	4.51e-07	0.000186	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—JUN—sarcoma	4.5e-07	0.000186	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—VEGFA—sarcoma	4.48e-07	0.000185	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CTNNB1—sarcoma	4.47e-07	0.000184	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IL2—sarcoma	4.46e-07	0.000184	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—VEGFA—sarcoma	4.46e-07	0.000184	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—SRC—sarcoma	4.45e-07	0.000184	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TP53—sarcoma	4.44e-07	0.000183	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CCND1—sarcoma	4.44e-07	0.000183	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—JUN—sarcoma	4.43e-07	0.000183	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CCND1—sarcoma	4.43e-07	0.000183	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—KRAS—sarcoma	4.43e-07	0.000183	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—NRAS—sarcoma	4.42e-07	0.000182	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—JUN—sarcoma	4.42e-07	0.000182	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—NRAS—sarcoma	4.4e-07	0.000182	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CTNNB1—sarcoma	4.4e-07	0.000181	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CTNNB1—sarcoma	4.39e-07	0.000181	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—SRC—sarcoma	4.38e-07	0.000181	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TP53—sarcoma	4.37e-07	0.00018	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—KRAS—sarcoma	4.37e-07	0.00018	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—HRAS—sarcoma	4.37e-07	0.00018	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CCND1—sarcoma	4.35e-07	0.000179	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—HRAS—sarcoma	4.34e-07	0.000179	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—JUN—sarcoma	4.34e-07	0.000179	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—VEGFA—sarcoma	4.33e-07	0.000179	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—HRAS—sarcoma	4.31e-07	0.000178	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CTNNB1—sarcoma	4.3e-07	0.000178	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—NRAS—sarcoma	4.28e-07	0.000177	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MYC—sarcoma	4.27e-07	0.000176	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—VEGFA—sarcoma	4.27e-07	0.000176	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—HRAS—sarcoma	4.25e-07	0.000175	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—NRAS—sarcoma	4.21e-07	0.000174	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—HRAS—sarcoma	4.18e-07	0.000172	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—EGFR—sarcoma	4.18e-07	0.000172	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TP53—sarcoma	4.17e-07	0.000172	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IL2—sarcoma	4.14e-07	0.000171	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MYC—sarcoma	4.12e-07	0.00017	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MYC—sarcoma	4.1e-07	0.000169	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CCND1—sarcoma	4.04e-07	0.000167	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—SRC—sarcoma	4.04e-07	0.000167	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—EGFR—sarcoma	4.03e-07	0.000166	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—JUN—sarcoma	4.03e-07	0.000166	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—EGFR—sarcoma	4.01e-07	0.000165	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CTNNB1—sarcoma	4e-07	0.000165	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—HRAS—sarcoma	3.99e-07	0.000165	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MYC—sarcoma	3.99e-07	0.000164	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—SRC—sarcoma	3.97e-07	0.000164	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—SRC—sarcoma	3.96e-07	0.000164	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—KRAS—sarcoma	3.94e-07	0.000163	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TP53—sarcoma	3.94e-07	0.000162	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—VEGFA—sarcoma	3.93e-07	0.000162	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MYC—sarcoma	3.92e-07	0.000162	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—EGFR—sarcoma	3.9e-07	0.000161	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—SRC—sarcoma	3.89e-07	0.00016	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—NRAS—sarcoma	3.88e-07	0.00016	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TP53—sarcoma	3.88e-07	0.00016	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—VEGFA—sarcoma	3.87e-07	0.00016	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—VEGFA—sarcoma	3.86e-07	0.000159	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—EGFR—sarcoma	3.84e-07	0.000158	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—NRAS—sarcoma	3.82e-07	0.000158	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—NRAS—sarcoma	3.81e-07	0.000157	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—KRAS—sarcoma	3.81e-07	0.000157	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—VEGFA—sarcoma	3.79e-07	0.000156	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—KRAS—sarcoma	3.79e-07	0.000156	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—HRAS—sarcoma	3.76e-07	0.000155	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—NRAS—sarcoma	3.74e-07	0.000154	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—HRAS—sarcoma	3.71e-07	0.000153	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—KRAS—sarcoma	3.68e-07	0.000152	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—KRAS—sarcoma	3.63e-07	0.00015	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MYC—sarcoma	3.62e-07	0.000149	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—SRC—sarcoma	3.61e-07	0.000149	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MYC—sarcoma	3.56e-07	0.000147	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MYC—sarcoma	3.55e-07	0.000147	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—EGFR—sarcoma	3.54e-07	0.000146	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—VEGFA—sarcoma	3.52e-07	0.000145	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TP53—sarcoma	3.51e-07	0.000145	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MYC—sarcoma	3.49e-07	0.000144	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—EGFR—sarcoma	3.48e-07	0.000144	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—NRAS—sarcoma	3.48e-07	0.000143	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—EGFR—sarcoma	3.47e-07	0.000143	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—EGFR—sarcoma	3.41e-07	0.000141	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TP53—sarcoma	3.38e-07	0.00014	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TP53—sarcoma	3.37e-07	0.000139	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—HRAS—sarcoma	3.35e-07	0.000138	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—KRAS—sarcoma	3.34e-07	0.000138	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—KRAS—sarcoma	3.29e-07	0.000136	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—KRAS—sarcoma	3.28e-07	0.000135	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TP53—sarcoma	3.27e-07	0.000135	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MYC—sarcoma	3.24e-07	0.000134	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—HRAS—sarcoma	3.24e-07	0.000134	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TP53—sarcoma	3.22e-07	0.000133	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—KRAS—sarcoma	3.22e-07	0.000133	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—HRAS—sarcoma	3.22e-07	0.000133	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—EGFR—sarcoma	3.17e-07	0.000131	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—HRAS—sarcoma	3.13e-07	0.000129	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—HRAS—sarcoma	3.08e-07	0.000127	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—KRAS—sarcoma	2.99e-07	0.000123	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TP53—sarcoma	2.97e-07	0.000123	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TP53—sarcoma	2.92e-07	0.000121	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TP53—sarcoma	2.92e-07	0.00012	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TP53—sarcoma	2.86e-07	0.000118	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—HRAS—sarcoma	2.84e-07	0.000117	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—HRAS—sarcoma	2.8e-07	0.000115	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—HRAS—sarcoma	2.79e-07	0.000115	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—HRAS—sarcoma	2.74e-07	0.000113	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TP53—sarcoma	2.66e-07	0.00011	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—HRAS—sarcoma	2.54e-07	0.000105	CbGpPWpGaD
